scholarly journals Episcissors-60 for Mediolateral Episiotomy: Evaluation of Clinical and Economic Evidence to Inform NICE Medical Technologies Guidance

Author(s):  
Susan O’Connell ◽  
Megan Dale ◽  
Helen Morgan ◽  
Bernice Dillon ◽  
Andrew Cleves ◽  
...  
2001 ◽  
Author(s):  
Christopher G. Blood ◽  
◽  
Julia Fridman ◽  
G. Jay Walker ◽  
Juan Carlos Puyana ◽  
...  

2019 ◽  
Vol 2019 (6) ◽  
pp. 30-35
Author(s):  
Алан Карсанов ◽  
Alan Karsanov ◽  
Наталья Полунина ◽  
Natal'ya Polunina

The combined nature of the factors that threaten the patient and the complex subordination of many clinical risks are the basis of the authors' perception of the safety of medical activity (SMA) as a complex problem, the solution of which should be sought in improving managerial measures of a systemic nature. As structural components of an integrated approach to providing SMA, measures should be implemented aimed at increasing staff motivation, at increasing the level of medical communications, at introducing modern diagnostic and medical technologies, at improving the control and administrative component based on the industrial model of healthcare organization.


Author(s):  
Patricia J. Zettler ◽  
Erika Lietzan

This chapter assesses the regulation of medical devices in the United States. The goal of the US regulatory framework governing medical devices is the same as the goal of the framework governing medicines. US law aims to ensure that medical devices are safe and effective for their intended uses; that they become available for patients promptly; and that manufacturers provide truthful, non-misleading, and complete information about the products. US medical device law is different from US medicines law in many ways, however, perhaps most notably because most marketed devices do not require pre-market approval. The chapter explores how the US Food and Drug Administration (FDA) seeks to accomplish its mission with respect to medical devicecough its implementation of its medical device authorities. It starts by explaining what constitutes a medical device and how the FDA classifies medical devices by risk level. The chapter then discusses how medical devices reach the market, the FDA's risk management tools, and the rules and incentives for innovation and competition. It concludes by exploring case studies of innovative medical technologies that challenge the traditional US regulatory scheme to consider the future of medical device regulation.


Sign in / Sign up

Export Citation Format

Share Document